Wantai BioPharm

Wantai BioPharm, founded in 1991, is a leading high-tech enterprise specializing in the research, development, and production of biological diagnostic tests and vaccines. Committed to its mission of 'Advancing Human Health Through Biotechnology', the company translates cutting-edge scientific innovations into reliable, high-quality healthcare solutions. It has seven subsidiaries and its products cover a wide range of fields, including Total laboratory solution (TLA), biochemistry, chemiluminescence, Immunoassays, colloidal gold tests, molecular, bioactive materials, quality control products, and vaccines. Wantai BioPharm also collaborates with Xiamen University to establish the National Institute of Diagnostics and Vaccine Development (NIDVD), driving cutting-edge R&D with global impact. Its subsidiary, Innobiomax, focuses on the research, development, production, and sales of bioactive raw materials, offering over 300 antigens, antibodies, and core enzymes for immunoassays and clinical biochemistry reagents.